StockData
NeuroPace Inc logo

NeuroPace Inc (NPCE) income statement

NPCENasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/3028% above fair value
$8.22+0.02 (+0.24%)

Close on Nov 18, 2026Market cap $282.15MP/E –Yield 0.00%

NeuroPace Inc income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
79.6%
Operating margin
-15.3%
Net margin
-19.3%
Return on equity, FY2025
-158.7%

Financial strength

Current ratio
4.94
Debt to equity
4.97
Debt to assets
60.8%
Cash to current liabilities
71.9%

Valuation

P/E ratio
–
Price to sales
2.85
Price to book
23.74
Dividend yield
0.00%

See a number that looks wrong?